Lung cancer is the uncontrolled growth of abnormal cells that start off in one or both lungs and one of the causes of lung cancer is cigarette smoking. In view of that, I am particularly concern as smoking has slowly being accepted as a social behavior in the world and the number of people smoking has increased dramatically compared to the past. Lung cancer has since been a rising issue in recent years as many people start to take up the habit of smoking.
A recent article by Medical News Today reports that there has been a new discovery that was already in the phrase of co-clinical trials (conducting trials in parallel with human clinical trials!) for treatment of lung cancer, bringing in new hopes for the treatment of lung cancer. This work is recently being published in the scientific journal, Cancer Cell based on the research conducted by the Tumor Suppression Group of Spanish National Cancer Research Centre (CNIO). The major finding that they discovered is that they had identified an experimental drug that could prevent lung cancer growth in genetically modified mice (which has human lung cancer cells in them).
Since the experiment is in the phrase of co-clinical trial, I do not think that it will be a long wait for the drug to be up on the rack soon!
To read the full article, click here.
Leading scientists will be presenting at our 6th Annual Biopharma Asia 2013. We will be holding an oncology symposium that will showcase the latest oncology R&D developments in Asia. Contact Rebecca Koh at +65 6322 2725 or email@example.com to find out more about it! Visit our website here.